[go: up one dir, main page]

WO2008018110A3 - Use of nifedipine in anti -wrinkle compositions - Google Patents

Use of nifedipine in anti -wrinkle compositions Download PDF

Info

Publication number
WO2008018110A3
WO2008018110A3 PCT/IT2007/000577 IT2007000577W WO2008018110A3 WO 2008018110 A3 WO2008018110 A3 WO 2008018110A3 IT 2007000577 W IT2007000577 W IT 2007000577W WO 2008018110 A3 WO2008018110 A3 WO 2008018110A3
Authority
WO
WIPO (PCT)
Prior art keywords
nifedipine
treatment
wrinkle compositions
wrinkle
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IT2007/000577
Other languages
French (fr)
Other versions
WO2008018110A2 (en
Inventor
Carmine Antropoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008018110A2 publication Critical patent/WO2008018110A2/en
Publication of WO2008018110A3 publication Critical patent/WO2008018110A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nifedipine, a well-known calcium antagonist of the dihydropyridine type already used in the care of and treatment of many disorders, applied topically, is capable of relaxing the muscles responsible for the formation of wrinkles. The invention also includes nif edipine-based preparations for anti-wrinkle treatment.
PCT/IT2007/000577 2006-08-10 2007-08-08 Use of nifedipine in anti -wrinkle compositions Ceased WO2008018110A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2006A000440 2006-08-10
ITRM20060440 ITRM20060440A1 (en) 2006-08-10 2006-08-10 USE OF THE NIFEDIPINE FOR ANTI-WRINKLE TREATMENT

Publications (2)

Publication Number Publication Date
WO2008018110A2 WO2008018110A2 (en) 2008-02-14
WO2008018110A3 true WO2008018110A3 (en) 2008-04-03

Family

ID=38969929

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2007/000577 Ceased WO2008018110A2 (en) 2006-08-10 2007-08-08 Use of nifedipine in anti -wrinkle compositions

Country Status (2)

Country Link
IT (1) ITRM20060440A1 (en)
WO (1) WO2008018110A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393416B1 (en) * 2009-02-23 2012-04-20 Antropoli NIFEDIPINE COMPOSITIONS FOR ANTI-WRINKLE TREATMENTS
CN112972444B (en) * 2021-02-19 2022-07-26 中国医学科学院整形外科医院 Application of mexiletine in preparation of product for treating and/or preventing facial and neck skin wrinkles

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276643A2 (en) * 1986-09-04 1988-08-03 Jan Coppe Composition of a hair growth restorer
WO1991002497A1 (en) * 1989-08-21 1991-03-07 Beth Israel Hospital Association Topical nifedipine for cutaneous, ocular, mucosal hypersensitivity, inflammatory and hyperproliferative conditions
US5912008A (en) * 1992-11-06 1999-06-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic system for the release of 17-β-estradiol and process for its production
FR2806906A1 (en) * 2000-04-04 2001-10-05 C F E B Sisley Composition for use on the skin surrounding the eyes and mouth as an anti-aging, anti- wrinkle and anti-bagging formulation, comprises as an active agent an extract of brown algae
US20020058682A1 (en) * 1999-05-18 2002-05-16 Lionel Breton Treating skin wrinkles/fine lines with calcium channel inhibitors
WO2002049603A1 (en) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions for prevention and alleviation of skin wrinkles
EP1321136A1 (en) * 2001-12-20 2003-06-25 Coreana Cosmetics Co., Ltd. Cosmetic compositions of powder-type containing anti-wrinkling ingredients
JP2004123583A (en) * 2002-10-01 2004-04-22 Kose Corp Cosmetic
US20050186171A1 (en) * 2004-02-23 2005-08-25 Winick Bernyce A. Skin cream

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276643A2 (en) * 1986-09-04 1988-08-03 Jan Coppe Composition of a hair growth restorer
WO1991002497A1 (en) * 1989-08-21 1991-03-07 Beth Israel Hospital Association Topical nifedipine for cutaneous, ocular, mucosal hypersensitivity, inflammatory and hyperproliferative conditions
US5912008A (en) * 1992-11-06 1999-06-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic system for the release of 17-β-estradiol and process for its production
US20020058682A1 (en) * 1999-05-18 2002-05-16 Lionel Breton Treating skin wrinkles/fine lines with calcium channel inhibitors
FR2806906A1 (en) * 2000-04-04 2001-10-05 C F E B Sisley Composition for use on the skin surrounding the eyes and mouth as an anti-aging, anti- wrinkle and anti-bagging formulation, comprises as an active agent an extract of brown algae
WO2002049603A1 (en) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions for prevention and alleviation of skin wrinkles
EP1321136A1 (en) * 2001-12-20 2003-06-25 Coreana Cosmetics Co., Ltd. Cosmetic compositions of powder-type containing anti-wrinkling ingredients
JP2004123583A (en) * 2002-10-01 2004-04-22 Kose Corp Cosmetic
US20050186171A1 (en) * 2004-02-23 2005-08-25 Winick Bernyce A. Skin cream

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHO SOYUN; LOWE LORI; HAMILTON TED A; FISHER GARY J; VOORHEES JOHN J; KANG SEWON: "Long-term treatment of photoaged human skin with topical retinoic acid improves epidermal cell atypia and thickens the collagen band in papillary dermis.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 53, no. 5, November 2005 (2005-11-01), pages 769 - 774, XP002467168 *

Also Published As

Publication number Publication date
ITRM20060440A1 (en) 2008-02-11
WO2008018110A2 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2007019439A3 (en) Block copolymer compositions and uses thereof
TW200618817A (en) Diffractive colorants for cosmetics
WO2002092026A3 (en) Dermatological and cosmetic compositions
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
WO2004066918A3 (en) Long wear cosmetic composition
WO2007058602A3 (en) Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
WO2007129270A3 (en) Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
WO2004000293A3 (en) Use of taurine or derivatives thereof for the treatment of alopecia
WO2008104385A8 (en) Method for the treatment of amyloidoses
WO2007132134A3 (en) Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
WO2007039058A3 (en) Use of opioid receptor antagonists
WO2008031940A3 (en) Xanthoxyline-based composition and cosmetic use thereof
EP1874298A4 (en) Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3,1,0]hexanes
WO2008122517A3 (en) Sunscreen compositions comprising a random terpolymer
WO2010077976A3 (en) Prokineticin receptor antagonists and uses thereof
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2008018110A3 (en) Use of nifedipine in anti -wrinkle compositions
CA2554696A1 (en) Androgen receptor modulators
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
WO2008094054A3 (en) 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07805768

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07805768

Country of ref document: EP

Kind code of ref document: A2